Pharma Reviews
Pages
Home
Pharma News
US FDA News
Pharma Jobs
Wednesday, September 6, 2017
US FDA News: Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Recommends Separating Dosing
Too much potassium in the blood can cause problems with heart rhythm, which in rare cases can be fatal.
Read more:
Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Recommends Separating Dosing
Newer Post
Older Post
Home